Molecular formula: C₅₉H₇₉N1₅O₂₁S₆
Molecular weight: 1526. 736
Patent period: —
Dositive specifications: –
Injection : —
Oral tablets: —
Injection: —
Molecular formula: C₅₉H₇₉N1₅O₂₁S₆
Molecular weight: 1526. 736
Patent period: —
Dositive specifications: –
Injection : —
Oral tablets: —
Injection: —
Linaclotide is a potent and selective guanylate cyclase C agonist; Developed for the treatment of constipation-type irritable bowel syndrome (IBS-C) and chronic constipation.
_ LINACLOTIDE
_ LINZEESS
| ACTIONS | — |
|---|---|
| CAS NO. | 851199-59-2 |
| FORMULA | C₅₉H₇₉N1₅O₂₁S₆ |
| M. WT | 1526. 736 |
| PURITY | > 98% |
| SYNONYMS | Linzees |
| STORAGE | — |